Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?
Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed),